The potential of aromatase inhibitors in fish masculinization: a comprehensive review of applications, mechanisms and future perspectives.

Autor: Lal, Jham¹, Vaishnav, Anand¹, Khogen Singh, Soibam¹ gengang@gmail.com, Biswas, Pradyut¹, Kumar Mehta, Naresh¹, Kumar Meena, Dharmendra^1,2 dkmeenacifri@gmail.com, Waikhom, Gusheinzed¹

Publikováno v: International Aquatic Research. Jun2024, Vol. 16 Issue 2, p113-142. 30p.

Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.

Autor: Zhang, Li^1,2,3 (AUTHOR), Mei, Xin^1,2,3 (AUTHOR), Hu, Zhigang⁴ (AUTHOR), Yu, Bo⁵ (AUTHOR), Zhang, Chaoyang⁶ (AUTHOR), Li, Yong⁷ (AUTHOR), Liu, Kaitai⁸ (AUTHOR), Ma, Xuejun^1,2,3 (AUTHOR), Ma, Jinli^1,2,3 (AUTHOR), Chen, Xingxing^1,2,3 (AUTHOR), Meng, Jin^1,2,3 (AUTHOR), Shi, Wei^1,2,3 (AUTHOR), Wang, Xiaofang^1,2,3 (AUTHOR), Mo, Miao⁹ (AUTHOR), Shao, Zhimin^10,11 (AUTHOR), Zhang, Zhen^1,2,3 (AUTHOR), Yu, Xiaoli^1,2,3 (AUTHOR), Guo, Xiaomao^1,2,3 (AUTHOR) guoxm1800@163.com, Yang, Zhaozhi^1,2,3,12 (AUTHOR) yzzhi2014@163.com

Publikováno v: BMC Cancer. 1/9/2024, Vol. 24 Issue 1, p1-11. 11p.

Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer.

Autor: Rocca, Carmine¹ (AUTHOR), Soda, Teresa² (AUTHOR), De Francesco, Ernestina Marianna³ (AUTHOR), Fiorillo, Marco⁴ (AUTHOR), Moccia, Francesco⁵ (AUTHOR), Viglietto, Giuseppe⁶ (AUTHOR), Angelone, Tommaso^1,7 (AUTHOR) tommaso.angelone@unical.it, Amodio, Nicola⁶ (AUTHOR) amodio@unicz.it

Publikováno v: Journal of Translational Medicine. 9/19/2023, Vol. 21 Issue 1, p1-33. 33p.

Prognostic Factors for Survival in Hepatocellular Carcinoma

Autor: Falkson, G, Cnaan, A, Schutt, AJ, Ryan, LM, Falkson, HC

Associations between patient characteristics and survival were investigated in 432 patients with hepatocellular carcinoma. Those patients were prospectively studied by the Eastern Cooperative Oncology Group, and each had his or her diagnosis reconfir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::ac836576be88b3574cb8393fdc7b3907
https://hdl.handle.net/10453/26200

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer.

Autor: Falkson CI; Department of Medical Oncology, University of Pretoria, South Africa., Falkson HC

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1996 Jul; Vol. 7 (5), pp. 465-9.